SEC Form 4 · accession 0001209191-18-009167
Allena Pharmaceuticals, Inc. · ALNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexey L Margolin
Officer — Chief Executive Officer · Director
Period of report
Feb 9, 2018
Accepted (ET)
Feb 12, 2018 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624658
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.91 | Feb 9, 2018 | A | 190,000 | A | — | Feb 8, 2028 | Common Stock | 190,000 | 190,000 | D |
Explanation of responses
- F1Shares vest in 48 equal monthly installments beginning March 9, 2018
Remarks
Exhibit 24.1 - Power of Attorney